» Articles » PMID: 15568818

Mechanism of Inhibition of Human KSP by Monastrol: Insights from Kinetic Analysis and the Effect of Ionic Strength on KSP Inhibition

Overview
Journal Biochemistry
Specialty Biochemistry
Date 2004 Dec 1
PMID 15568818
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Kinesin motor proteins utilize the energy from ATP hydrolysis to transport cellular cargo along microtubules. Kinesins that play essential roles in the mechanics of mitosis are attractive targets for novel antimitotic cancer therapies. Monastrol, a cell-permeable inhibitor that specifically inhibits the kinesin Eg5, the Xenopus laevis homologue of human KSP, can cause mitotic arrest and monopolar spindle formation. In this study, we show that the extent of monastrol inhibition of KSP microtubule-stimulated ATP hydrolysis is highly dependent upon ionic strength. Detailed kinetic analysis of KSP inhibition by monastrol in the presence and absence of microtubules suggests that monastrol binds to the KSP-ADP complex, forming a KSP-ADP-monastrol ternary complex, which cannot bind to microtubules productively and cannot undergo further ATP-driven conformational changes.

Citing Articles

Transition-Metal Catalyzed Synthesis of Pyrimidines: Recent Advances, Mechanism, Scope and Future Perspectives.

Maikhuri V, Mathur D, Chaudhary A, Kumar R, Parmar V, Singh B Top Curr Chem (Cham). 2024; 382(1):4.

PMID: 38296918 DOI: 10.1007/s41061-024-00451-2.


Preliminary study on the clinical significance of kinesin Kif18a in nonsmall cell lung cancer: An analysis of 100 cases.

Guo W, Zeng H, Zheng J, He Y, Zhuang X, Cai J Medicine (Baltimore). 2020; 99(4):e19011.

PMID: 31977917 PMC: 7004722. DOI: 10.1097/MD.0000000000019011.


Small molecule allosteric uncoupling of microtubule depolymerase activity from motility in human Kinesin-5 during mitotic spindle assembly.

Kim C, Kim E, Liu L, Buckley R, Parameswaran S, Kim S Sci Rep. 2019; 9(1):19900.

PMID: 31882607 PMC: 6934681. DOI: 10.1038/s41598-019-56173-9.


Dihydropyrimidine-2-thiones as Eg5 inhibitors and L-type calcium channel blockers: potential antitumour dual agents.

Gonzalez-Hernandez E, Aparicio R, Garayoa M, Montero M, Sevilla M, Perez-Melero C Medchemcomm. 2019; 10(9):1589-1598.

PMID: 31673316 PMC: 6786242. DOI: 10.1039/c9md00108e.


Insights into the Molecular Mechanisms of Eg5 Inhibition by (+)-Morelloflavone.

Ogunwa T, Laudadio E, Galeazzi R, Miyanishi T Pharmaceuticals (Basel). 2019; 12(2).

PMID: 30995725 PMC: 6630617. DOI: 10.3390/ph12020058.